DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.22
-0.10 (-1.58%)
At close: Apr 28, 2026, 4:00 PM EDT
6.22
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $335.15 million as of April 28, 2026. Its market cap has increased by 122.84% in one year.
Market Cap
335.15M
Enterprise Value
275.50M
1-Year Change
122.84%
Ranking
Category
Stock Price
$6.22
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $335.15M, an increase of 813.21%. That is a compound annual growth rate of 34.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 340.50M | -17.85% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| vTv Therapeutics | 361.99M |
| Monopar Therapeutics | 351.47M |
| Rezolute | 343.30M |
| Surrozen | 342.02M |
| Nautilus Biotechnology | 340.46M |
| Palisade Bio | 334.85M |
| Bicycle Therapeutics | 332.85M |
| Greenwich LifeSciences | 332.75M |